Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report
-
* Corresponding author: Martin F Sprinzl sprinzl@1-med.klinik.uni-mainz.de
- Equal contributors
BMC Cancer 2006, 6:190 doi:10.1186/1471-2407-6-190
Accesses
- Last 30 days: 29 accesses
- Last 365 days: 380 accesses
- All time: 3639 accesses